Error in the PBS listings for methylphenidate hydrochloride modified release tablet (Concerta, Methylphenidate-TEVA XR, Methylphenidate XR ARX)
04 Dec 2024
The population criteria for methylphenidate hydrochloride modified release tablet for the treatment of attention deficit hyperactivity disorder (PBS Item codes 2172H, 2387P, 2388Q, 2432B) has been incorrectly changed to:
“Patient must be or have been diagnosed between the ages of 6 and 17 years inclusive.”
The population criteria for these item codes should be “Patient must be or have been diagnosed between the ages of 6 and 18 years inclusive.”
The population criteria for item codes 2172H, 2387P, 2388Q, 2432B will be corrected in the PBS schedule from 1 January 2025.
Categories
- MBS
- PBS
- The Department Of Health And Aged Care
- RACGP
- NIP
- AHPRA
- NSW Health
- Queensland Health
- Victoria Health
- Tasmania News
- Western Australia
- SA Health
- NT HEALTH
- Pharmacy Board Of Ahpra
- National Asthma Council
- NT
- AMA
- NACCHO
- BCNA
- Australian College Of Nurse Practitioners
- Asthma Australia
- LFA
- Palliative Care
- Primary Health Network
- AIHW
- Children's Health Queenland
- Kidney Health
- CHF
- MHC
- Gold Coast
- Tsa
- TGA
- Medicine Shortage
Popular Posts
Tags
- Environmental health National Health and Climate Strategy environmental-health-national-health-and-climate-strategy
